Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites.

BACKGROUND The currently used standards for human chorionic gonadotropin (hCG) and its alpha and beta subunits (hCGalpha and hCGbeta) contain substantial amounts of contaminating variants of hCG and other impurities. Furthermore, some partially degraded forms of hCG and its subunits have become of potential clinical importance, e.g., "nicked" forms of hCG (hCGn) and hCGbeta (hCGbetan), which contain cuts in the peptide backbone between amino acids 44-45 or 47-48 in hCGbeta, and a fragment of hCGbeta (hCGbetacf) consisting of amino acids 6-40 and 55-92 bound together by disulfide bridges. The IFCC appointed a working group with the aim of preparing new standards for hCG and related substances to improve standardization of their immunoassays. METHODS Large amounts of hCG and its subunits as well as of hCGn, hCGbetan, and hCGbetacf were prepared by previously developed purification methods in combination with hydrophobic interaction chromatography and reversed-phase HPLC. Each preparation was characterized on the basis of amino acid and sequence analyses, carbohydrate composition, and electrophoretic patterns. Immunoassays for relevant contaminating proteins were also performed. RESULTS The major preparations were homogeneous and free of contaminating proteins. Concentrations of the final preparations were determined by amino acid analysis. CONCLUSIONS Calibrated in substance concentrations (mol/L) based on amino acid analyses, these preparations will facilitate improved standardization of immunoassays for hCG and its metabolites. The six preparations have now been established by the WHO as new 1st Reference Reagents for immunoassays with the following codes: hCG 99/688, hCGbeta 99/650, hCGalpha 99/720, hCGn 99/642, hCGbetan 99/692, and hCGbetacf 99/708. In contrast to the 3rd International Standard (75/537), the clinically most important Reference Reagent for hCG (99/688) contains no hCGn and negligible amounts of free subunits.

[1]  A. Renwick,et al.  Separation of human glycoprotein hormones and their subunits by reversed-phase liquid chromatography. , 1990, Journal of chromatography.

[2]  D. Merkel,et al.  Taxol and radiation recall dermatitis , 1993, The Lancet.

[3]  G. Wick,et al.  Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay. , 1988, Endocrinology.

[4]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. , 1991, Endocrinology.

[5]  R. Canfield,et al.  Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. , 1994, Endocrine reviews.

[6]  K. Catt,et al.  In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay. , 1976, The Journal of clinical endocrinology and metabolism.

[7]  S. Madersbacher,et al.  Monoclonal antibodies against the free subunits of human chorionic gonadotrophin. , 1990, The Journal of endocrinology.

[8]  S. Birken,et al.  Preparation and analysis of the common urinary forms of human chorionic gonadotropin. , 2000, Methods.

[9]  S. Birken,et al.  Metabolism of hCG and hLH to multiple urinary forms , 1996, Molecular and Cellular Endocrinology.

[10]  T. Bramley,et al.  Co-purification of a ribonuclease and human chorionic gonadotrophin β-core protein from human urine and displacement of 125I-human luteinizing hormone from Candida albicans binding sites by ribonucleases , 1997, Molecular and Cellular Endocrinology.

[11]  M. Sauer,et al.  Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. , 2002, The Journal of endocrinology.

[12]  S. Madersbacher,et al.  Antibodies and immunoassays. , 2000, Methods.

[13]  E. Diczfalusy,et al.  An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. , 1974, Acta endocrinologica.

[14]  U. Stenman,et al.  Pregnancy Serum Contains the β-Core Fragment of Human Choriogonadotropin , 1990 .

[15]  S. Birken,et al.  Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples. , 1993, Endocrinology.

[16]  C. Théodore,et al.  Free hCG-β subunit as tumour marker in urothelial cancer , 1993, The Lancet.

[17]  S. Dirnhofer,et al.  Time-resolved immunofluorometry and other frequently used immunoassay types for follicle-stimulating hormone compared by using identical monoclonal antibodies. , 1993, Clinical chemistry.

[18]  G. K. Scott,et al.  The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropin. , 1993, Endocrinology.

[19]  D. Blithe,et al.  β-Core fragments are contaminants of the World Health Organization Reference Preparations of human choriogonadotrophin and its α-subunit , 1988 .

[20]  S. Birken,et al.  Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. , 1999, The Journal of endocrinology.

[21]  L. Cole,et al.  Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. , 1988, Endocrinology.

[22]  C. Haglund,et al.  Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. , 1992, Cancer research.

[23]  L. Cole,et al.  Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. , 1999, Clinical chemistry.

[24]  D. Bangham,et al.  International Reference Preparation of Human Chorionic Gonadotrophin for Immunoassay: potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the alpha and beta subunits of human chorionic gonadotrophin for immunoassay. , 1980, The Journal of endocrinology.

[25]  L. Cole,et al.  The heterogeneity of human chorionic gonadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. , 1991, Endocrinology.

[26]  L. Cole,et al.  Characterization of antisera distinguishing carbohydrate structures in the beta-carboxyl-terminal region of human chorionic gonadotropin. , 1988, Endocrinology.

[27]  J. Bidart,et al.  Standardization of protein immunoprocedures. Choriogonadotropin (CG). , 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[28]  G. Spoettl,et al.  Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies. , 1993, The Journal of clinical endocrinology and metabolism.

[29]  G T Ross,et al.  A new reference preparation of human chorionic gonadotrophin and its subunits. , 1976, Bulletin of the World Health Organization.

[30]  R. Canfield,et al.  Properties of the subunits of human chorionic gonadotropin. , 1974, Endocrinology.

[31]  S. Birken,et al.  Metabolism of gonadotropins: comparisons of the primary structures of the human pituitary and urinary LH beta cores and the chimpanzee CG beta core demonstrate universality of core production. , 2001, The Journal of endocrinology.

[32]  C. Sturgeon,et al.  The ISOBM TD-7 Workshop on hCG and Related Molecules , 2002, Tumor Biology.